Clinical Trial Update: Bypass Surgery and CD133 Marrow Cell Injection for Treatment of Ischemic Heart Failure [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports completion of Phase 2/3 testing of bypass surgery with CD133-positive marrow cell injections for ischemic heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Artery Disease
• Heart Failure
• Myocardial Infarction
• Myocardial Ischemia

Drugs mentioned

• CD133 Marrow Cell Injection

Snippet

Sponsor: German Heart Institute | Conditions: Coronary Artery Disease With Need for Bypass Surgery, Myocardial Ischemia, Angina Pectoris | Phase 2, Phase 3 | Status: COMPLETED